AtriCure to Present at the Leerink Swann 2013 Global Healthcare Conference
WEST CHESTER, Ohio -- January 31, 2013
AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in
cardiac surgical ablation systems for the treatment of atrial fibrillation, or
AF, and systems for the exclusion of the left atrial appendage, today
announced that it will present at the Leerink Swann 2013 Global Healthcare
Conference at the Waldorf Astoria Hotel in New York on Thursday, February 14,
2013. Management is scheduled to present at2:30 p.m. Eastern Time.
A live audio webcast and replay of the presentation will be available for 30
days following the presentation at www.atricure.com.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing,
manufacturing and selling innovative cardiac surgical ablation systems
designed to create precise lesions, or scars, in cardiac, or heart, tissue for
the treatment of atrial fibrillation, or AF, and systems for the exclusion of
the left atrial appendage. For more information, please visit
Andy Wade, 513-755-4564
Vice President and Chief Financial Officer
Investor Relations Contact:
Lynn Pieper, 415-202-5678
Press spacebar to pause and continue. Press esc to stop.